Over-prescription of short-acting β 2 -agonists is associated with poor asthma outcomes: results from the African cohort of the SABINA III study.

Adel Khattab,Ashraf Madkour,Anish Ambaram,Clifford Smith,Chakaya J Muhwa,Jared O Mecha,Mohamed Alsayed,Maarten J H I Beekman

Current medical research and opinion（2022）

引用 8|浏览0

暂无评分

摘要

Findings from this African cohort of the SABINA III study indicate that SABA over-prescription and SABA over-the-counter purchase are common and associated with poor asthma-related outcomes. This highlights the need for healthcare providers/policymakers to align clinical practices with the latest treatment recommendations.

查看译文

关键词

Asthma,asthma control,burden,exacerbation,prescription,short-acting β2-agonist

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要